4//SEC Filing
Pauza Charles David 4
Accession 0002018150-25-000003
CIK 0001130598other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 8:08 PM ET
Size
5.6 KB
Accession
0002018150-25-000003
Insider Transaction Report
Form 4
Pauza Charles David
Chief Science Officer Virology
Transactions
- Award
Stock Option (right to purchase)
2025-10-12+32,406→ 32,406 totalExercise: $3.01From: 2026-10-12Exp: 2035-10-12→ Common Stock (32,406 underlying)
Footnotes (1)
- [F1]The options vest 100% on the first anniversary of the grant date.
Documents
Issuer
Traws Pharma, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0002018150
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 8:08 PM ET
- Size
- 5.6 KB